{
  "id": 6425697,
  "title": "Study Finds Ozempic May Cut Severe Asthma Attacks",
  "url": "https://urgent.news/2026/09/09/study-finds-ozempic-may-cut-severe-asthma-attacks",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-09-09T13:35:07.000Z",
  "source": {
    "name": "ProPakistani",
    "slug": "propakistani",
    "url": "https://propakistani.pk/2026/09/09/study-finds-ozempic-may-cut-severe-asthma-attacks/"
  },
  "original_language": "en",
  "account": "A new study indicates that weight-loss injections like Ozempic and Wegovy may help diminish the frequency of severe asthma attacks. British researchers claim that semaglutide, a GLP-1 receptor agonist employed to treat diabetes and aid weight loss, could lower the risk of dangerous escalation of asthma symptoms. Researchers also claim that previous investigations have suggested these medications might possess anti-inflammatory properties and could enhance lung-related outcomes. The research was spearheaded by Chloe Bloom, who stated that GLP-1 receptor agonists are already commonly used for type 2 diabetes and obesity. She pointed out that the medications may have additional advantages beyond their present applications. Researchers examined UK electronic medical records and conducted four separate investigations. Each study encompassed approximately 20,000 to 22,000 individuals who had either begun GLP-1 therapy or were using sulfonylurea, another diabetes medication. The findings revealed that asthma and COPD patients prescribed GLP-1 medications experienced fewer asthma attacks and fewer sudden deterioration episodes of COPD compared to those taking other diabetes medications. Bloom, who is affiliated with Imperial College London’s National Heart and Lung Institute, noted that the impact was most pronounced with semaglutide. In asthma patients, its usage was associated with approximately a 40 percent decline in asthma attacks. Researchers posited that the outcomes suggest a potential connection between GLP-1 medications and respiratory ailments. However, they emphasized that additional research is required to ascertain whether these drugs are secure and effective as asthma treatments.",
  "summary": "A new study suggests that weight-loss injections such as Ozempic and Wegovy may help reduce sudden and severe asthma attacks. … Read More The post Study Finds Ozempic May Cut Severe Asthma Attacks appeared first on ProPakistani .",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}